BNP Paribas Financial Markets
BMRA icon

BNP Paribas Financial Markets’s Biomerica BMRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$393 – 4118
2022
Q3 		$393 Buy
+13
New +$337 ﹤0.01% 4549

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $244M AUM
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

BNP Paribas Financial Markets's BMRA Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Biomerica (BMRA) in Q4 2022, closing a stake of 13 shares — an estimated $393 sold.

BNP Paribas Financial Markets first reported a position in BMRA in Q3 2022 and held it in 1 quarter. The position peaked at $393 in Q3 2022. 30 funds tracked by Wall St. Rank hold BMRA as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Biomerica position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 13 Biomerica shares in Q4 2022, an estimated $393.
  • BNP Paribas Financial Markets first reported a position in Biomerica in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Biomerica position peaked at $393 in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Biomerica as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.